Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New ...
Journal of Nuclear Medicine February 2025, jnumed.124.268079; DOI: https://doi.org/10.2967/jnumed.124.268079 ...
Journal of Nuclear Medicine February 2025, jnumed.124.269024; DOI: https://doi.org/10.2967/jnumed.124.269024 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Journal of Nuclear Medicine February 2025, jnumed.124.269401; DOI: https://doi.org/10.2967/jnumed.124.269401 ...
Journal of Nuclear Medicine February 2025, jnumed.124.267809; DOI: https://doi.org/10.2967/jnumed.124.267809 ...
Radiopharmaceutical therapy (RPT), with its targeted delivery of cytotoxic ionizing radiation, demonstrates significant potential for treating a wide spectrum of malignancies, with particularly unique ...
Reply: A Comment on “Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study” ...
Between June 2013 and April 2018, datasets from 7,013 patients with PSMA PET for PCa were retrospectively reviewed at 6 high-volume nuclear medicine centers, and 16 patients with PSA persistence after ...
S.J. McPhee, M.A. Papadakis, and L.M. Tierney, Jr., eds. New York, NY: McGraw Hill Medical, 2008, 1,673 pages, $69.95 Medicine is an ever-changing field, and changes ...
Objectives The aim of this study is to employ a pretargeted approach that leverages the power of a supramolecular nanoparticle (SNP) vector and in vivo bioorthogonal ...